Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis
出版年份 2015 全文链接
标题
Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis
作者
关键词
Adverse effects, Aromatase inhibitors, Breast cancer, Clinical outcomes, <em class=EmphasisTypeItalic >CYP19A1</em>, Meta-analysis, Pharmacogenetics, Systematic review
出版物
BMC Medicine
Volume 13, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-06-11
DOI
10.1186/s12916-015-0373-9
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial
- (2014) Duveken B. Y. Fontein et al. BREAST CANCER RESEARCH AND TREATMENT
- Genetic polymorphism at Val80 (rs700518) of the CYP19A1 gene is associated with aromatase inhibitor associated bone loss in women with ER (+) breast cancer
- (2013) Nicola Napoli et al. BONE
- Meta-analysis of breast cancer outcome and toxicity in adjuvant trials of aromatase inhibitors in postmenopausal women
- (2013) Adnan Aydiner BREAST
- Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer
- (2013) N. Lynn Henry et al. BREAST CANCER RESEARCH AND TREATMENT
- A Polymorphism at the 3'-UTR Region of the Aromatase Gene Is Associated with the Efficacy of the Aromatase Inhibitor, Anastrozole, in Metastatic Breast Carcinoma
- (2013) Lei Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Endometrial Intracrinology—Generation of an Estrogen-dominated Microenvironment in the Secretory Phase of Women
- (2013) D. A. Gibson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole
- (2012) G. Lunardi et al. BREAST CANCER RESEARCH AND TREATMENT
- Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients
- (2012) Roberta Ferraldeschi et al. BREAST CANCER RESEARCH AND TREATMENT
- Pharmacogenetics of aromatase inhibitors
- (2012) Kristen D Hadfield et al. PHARMACOGENOMICS
- The 2,2′,4,4′-tetrabromodiphenyl ether hydroxylated metabolites 5-OH-BDE-47 and 6-OH-BDE-47 stimulate estradiol secretion in the ovary by activating aromatase expression
- (2012) Anna Karpeta et al. TOXICOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Single nucleotide polymorphisms of CYP19A1 predict clinical outcomes and adverse events associated with letrozole in patients with metastatic breast cancer
- (2011) In Hae Park et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Aromatase, aromatase inhibitors, and breast cancer
- (2011) Saranya Chumsri et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis
- (2011) Eitan Amir et al. JNCI-Journal of the National Cancer Institute
- A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole
- (2010) Zaida Garcia-Casado et al. BMC CANCER
- Association between CYP19 polymorphisms and breast cancer risk: results from 10,592 cases and 11,720 controls
- (2010) Xiangyu Ma et al. BREAST CANCER RESEARCH AND TREATMENT
- Functional Genetic Polymorphisms in the Aromatase Gene CYP19 Vary the Response of Breast Cancer Patients to Neoadjuvant Therapy with Aromatase Inhibitors
- (2010) L. Wang et al. CANCER RESEARCH
- A review of mechanistic studies on aromatase (CYP19) and 17α-hydroxylase-17,20-lyase (CYP17)
- (2010) Muhammad Akhtar et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
- (2009) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Association of genetic polymorphisms of ER-α and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women
- (2008) Lina Zhang et al. BREAST CANCER RESEARCH AND TREATMENT
- A Single-Nucleotide Polymorphism in the Aromatase Gene Is Associated with the Efficacy of the Aromatase Inhibitor Letrozole in Advanced Breast Carcinoma
- (2008) R. Colomer et al. CLINICAL CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started